SCHEMBL23697123

SCHEMBL23697123

CC(C)(O)c1ccccc1Oc1ccc(Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HTT P42858 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
RIPK1 Q13546 1/20 0.38
MAPT P10636 1/20 0.37
EZH2 Q15910 1/20 0.36
FFAR1 O14842 1/20 0.36
LMNA P02545 4/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HPGD P15428 1/20 0.34
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
LTA4H P09960 1/20 0.34
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL548378 0.85 RIPK1 (0.50) SLC6A2SLC6A4HTTL3MBTL1ALDH1A1
SCHEMBL17703261 0.83 PTGDR2 (0.42) SLC6A2SLC6A4SLC6A3HTTL3MBTL1
SCHEMBL17703260 0.82 CYP1A2 (0.42) SLC6A2SLC6A4SLC6A3ALDH1A1RIPK1
SCHEMBL17703255 0.80 SLC6A4 (0.42) SLC6A2SLC6A4SLC6A3HTTL3MBTL1
SCHEMBL2314095 0.79 LTA4H (0.51) SLC6A2SLC6A4SLC6A3HTTL3MBTL1
SCHEMBL3839100 0.77 ALDH1A1 (0.58) SLC6A2SLC6A4SLC6A3HTTL3MBTL1
SCHEMBL23279919 0.76 LMNA (0.39) SLC6A2SLC6A4SLC6A3HTTALDH1A1
SCHEMBL23696797 0.73 SLC6A4 (0.52) SLC6A2SLC6A4SLC6A3L3MBTL1ALDH1A1
SCHEMBL23697006 0.73 CYP3A4 (0.42) SLC6A2SLC6A4SLC6A3HTTMAPT
SCHEMBL29477934 0.73 SLC6A4 (0.55) SLC6A2SLC6A4SLC6A3HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
WO-2021149998-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME 덕산네오룩스 주식회사 2021-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME ORAI2, OR10J3, OR51E2 SLC6A2 4084/4885SLC6A4 3746/4885SLC6A3 4560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.